This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Cyproheptadine as an Appetite Stimulant

Sponsored by St. Justine's Hospital

About this trial

Last updated 14 years ago

Study ID

Cypro-24

Status

Unknown status

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
2 to 4 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 13 years ago

What is this trial about?

Cyproheptadine is currently clinically used as an appetite stimulant for children with failure to thrive without underlying organic disease. Otherwise, no randomised control trial demonstrates the efficacy of Cyproheptadine on those patients. This is precisely what the investigators intend to demonstrate on this randomised placebo control cross-over trial. Our hypothesis is that Cyproheptadine is more efficient than placebo to improve weight gain and feeding behaviour on 2 to 4 years old children with failure to thrive.

What are the participation requirements?

Yes

Inclusion Criteria

- 2 to 4 years of age

- failure to thrive

No

Exclusion Criteria

- Medication affecting appetite

- Medication interacting with Cyproheptadine

- Prematurity under 36 weeks of gestation

- Neurologic impairment

- underlying organic disease